Gonorrhoea Clinical Trial
Official title:
Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea: RaDAR-Go
The purpose of this study is to develop a laboratory-based assay that will be a real-time PCR test to detect the organism N. gonorrhoeae and its most important genetic markers of antimicrobial resistance. This study will also determine factors associated with gonorrhoea and describe sexual behaviours of men who have sex with men, to inform parameters for a mathematical model of gonorrhoea transmission and antimicrobial resistant gonorrhoea.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02257918 -
Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea
|
Phase 2 | |
| Completed |
NCT04722003 -
Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination
|
Phase 2 | |
| Completed |
NCT02348424 -
Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin
|
Phase 1 | |
| Completed |
NCT00926796 -
Efficacy of Combination Therapies for Gonorrhea Treatment
|
Phase 4 | |
| Terminated |
NCT03596151 -
Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs
|
N/A | |
| Completed |
NCT03404167 -
A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers
|
Phase 1 | |
| Completed |
NCT01949363 -
The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study
|
Phase 1 | |
| Completed |
NCT02708992 -
Cefixime / Azithromycin pK Study
|
Phase 1 |